PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MAMA vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MAMA and NVO is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

MAMA vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mama's Creations Inc. (MAMA) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
-4.29%
-39.95%
MAMA
NVO

Key characteristics

Sharpe Ratio

MAMA:

1.32

NVO:

-0.70

Sortino Ratio

MAMA:

1.99

NVO:

-0.80

Omega Ratio

MAMA:

1.24

NVO:

0.89

Calmar Ratio

MAMA:

2.08

NVO:

-0.55

Martin Ratio

MAMA:

6.85

NVO:

-1.48

Ulcer Index

MAMA:

9.63%

NVO:

17.13%

Daily Std Dev

MAMA:

50.01%

NVO:

36.27%

Max Drawdown

MAMA:

-64.79%

NVO:

-71.31%

Current Drawdown

MAMA:

-20.81%

NVO:

-46.24%

Fundamentals

Market Cap

MAMA:

$293.18M

NVO:

$352.92B

EPS

MAMA:

$0.08

NVO:

$2.93

PE Ratio

MAMA:

97.50

NVO:

26.86

Total Revenue (TTM)

MAMA:

$116.47M

NVO:

$204.72B

Gross Profit (TTM)

MAMA:

$29.28M

NVO:

$173.22B

EBITDA (TTM)

MAMA:

$8.81M

NVO:

$108.42B

Returns By Period

In the year-to-date period, MAMA achieves a -2.01% return, which is significantly higher than NVO's -8.52% return.


MAMA

YTD

-2.01%

1M

0.45%

6M

-4.29%

1Y

64.21%

5Y*

N/A

10Y*

N/A

NVO

YTD

-8.52%

1M

-25.74%

6M

-39.95%

1Y

-26.03%

5Y*

22.75%

10Y*

15.65%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MAMA vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MAMA
The Risk-Adjusted Performance Rank of MAMA is 8383
Overall Rank
The Sharpe Ratio Rank of MAMA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of MAMA is 8080
Sortino Ratio Rank
The Omega Ratio Rank of MAMA is 7676
Omega Ratio Rank
The Calmar Ratio Rank of MAMA is 9090
Calmar Ratio Rank
The Martin Ratio Rank of MAMA is 8686
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 1212
Overall Rank
The Sharpe Ratio Rank of NVO is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 1414
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 1313
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 1414
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 66
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MAMA vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mama's Creations Inc. (MAMA) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MAMA, currently valued at 1.32, compared to the broader market-2.000.002.004.001.32-0.70
The chart of Sortino ratio for MAMA, currently valued at 1.99, compared to the broader market-4.00-2.000.002.004.001.99-0.80
The chart of Omega ratio for MAMA, currently valued at 1.24, compared to the broader market0.501.001.502.001.240.89
The chart of Calmar ratio for MAMA, currently valued at 2.08, compared to the broader market0.002.004.006.002.08-0.55
The chart of Martin ratio for MAMA, currently valued at 6.85, compared to the broader market-10.000.0010.0020.0030.006.85-1.48
MAMA
NVO

The current MAMA Sharpe Ratio is 1.32, which is higher than the NVO Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of MAMA and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
1.32
-0.70
MAMA
NVO

Dividends

MAMA vs. NVO - Dividend Comparison

MAMA has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.83%.


TTM20242023202220212020201920182017201620152014
MAMA
Mama's Creations Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
1.83%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%

Drawdowns

MAMA vs. NVO - Drawdown Comparison

The maximum MAMA drawdown since its inception was -64.79%, smaller than the maximum NVO drawdown of -71.31%. Use the drawdown chart below to compare losses from any high point for MAMA and NVO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-20.81%
-46.24%
MAMA
NVO

Volatility

MAMA vs. NVO - Volatility Comparison

Mama's Creations Inc. (MAMA) has a higher volatility of 23.31% compared to Novo Nordisk A/S (NVO) at 21.75%. This indicates that MAMA's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
23.31%
21.75%
MAMA
NVO

Financials

MAMA vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Mama's Creations Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab